News und Analysen
This Trial Failure Dropped Versartis Inc 86.6% and Lifted Ascendis Pharma 51.4%
Shares of biopharma Versartis (NASDAQ: VSAR) crashed nearly 87% Friday after somavaratan, the company's lead drug candidate, did not meet its primary endpoint in the phase 3 Velocity trial. The....
This Trial Failure Dropped Versartis Inc 86.6% and Lifted Ascendis Pharma 51.4%
Shares of biopharma Versartis (NASDAQ: VSAR) crashed nearly 87% Friday after somavaratan, the company's lead drug candidate, did not meet its primary endpoint in the phase 3 Velocity trial. The....
AstraZeneca Stock Upgraded: What You Need to Know
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
AstraZeneca Stock Upgraded: What You Need to Know
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
Why Is Cash-Rich Gilead Sciences, Inc. Borrowing $3 Billion?
Last week, Gilead Sciences (NASDAQ: GILD) announced that it was borrowing $3 billion. That's billion with a "B."The company doesn't really need the money. It was sitting on $36.6 billion in cash,....
Why Is Cash-Rich Gilead Sciences, Inc. Borrowing $3 Billion?
Last week, Gilead Sciences (NASDAQ: GILD) announced that it was borrowing $3 billion. That's billion with a "B."The company doesn't really need the money. It was sitting on $36.6 billion in cash,....
Why Is Cash-Rich Gilead Sciences, Inc. Borrowing $3 Billion?
Last week, Gilead Sciences (NASDAQ: GILD) announced that it was borrowing $3 billion. That's billion with a "B."The company doesn't really need the money. It was sitting on $36.6 billion in cash,....
3 Big Biotech Stocks to Buy This Fall
A change in season presents a good time to look for great stocks to buy. And one of the best places to look is in the biotech industry. Biotech stocks in general are trouncing the S&P 500....
These 3 Stocks Are Priced for Perfection. Can They Deliver?
You expect a top-ranked football team to play well every game. You expect the Kentucky Derby winner to place in the Preakness Stakes. And you expect a stock with a high valuation to generate....
Better Buy: Celgene Corporation vs. Merck & Co., Inc.
Based on recent history, Celgene Corporation (NASDAQ: CELG) and Merck & Co. (NYSE: MRK) stocks don't even belong in the same league. Celgene stock is up more than 270% over the past five....
Better Buy: Celgene Corporation vs. Merck & Co., Inc.
Based on recent history, Celgene Corporation (NASDAQ: CELG) and Merck & Co. (NYSE: MRK) stocks don't even belong in the same league. Celgene stock is up more than 270% over the past five....
3 Biotech Stocks With Major Catalysts Incoming
Axovant Sciences Ltd (NASDAQ: AXON) and PTC Therapeutics, Inc. (NASDAQ: PTCT) have drugs in late-stage development that could propel them to profitability over the next few years. Gilead Sciences,....
Why Intercept Pharmaceuticals Is Tumbling Today
Intercept Pharmaceuticals (NASDAQ: ICPT), a biotech focused on liver diseases, fell 21% as of 3:26 p.m. EDT Thursday. The fall is traceable to a safety announcement released by the FDA that warns....
Billionaires Are Gobbling Up This Beaten-Down Biotech Stock: Should You?
Julian and Felix Baker of the $15.6 billion hedge fund Baker Bros. Advisors are well-known for their uncanny ability to unearth hidden gems in biotech and biopharma. So when I noticed that the....
3 Stocks to Help You Make Money in Retirement
Especially if you're looking forward to a long retirement, you'll still want to own some stocks after you've cashed your final paycheck. Unlike cash or many bonds these days, returns from stocks....
3 Stocks to Help You Make Money in Retirement
Especially if you're looking forward to a long retirement, you'll still want to own some stocks after you've cashed your final paycheck. Unlike cash or many bonds these days, returns from stocks....
3 Small-Cap Biotech Stocks to Buy This Fall
Hundreds of small-cap biotech stocks are available for investors. All of them come with relatively high levels of risk. With that high risk, though, also comes the potential for high returns.But....
3 Small-Cap Biotech Stocks to Buy This Fall
Hundreds of small-cap biotech stocks are available for investors. All of them come with relatively high levels of risk. With that high risk, though, also comes the potential for high returns.But....
Pfizer and Johnson & Johnson's Brewing Brawl Gets Real
Pfizer (NYSE: PFE) took direct aim at Johnson & Johnson (NYSE: JNJ) last year when it won FDA approval for Inflectra, a biosimilar to Johnson & Johnson's multi-billion dollar per year....
Pfizer and Johnson & Johnson's Brewing Brawl Gets Real
Pfizer (NYSE: PFE) took direct aim at Johnson & Johnson (NYSE: JNJ) last year when it won FDA approval for Inflectra, a biosimilar to Johnson & Johnson's multi-billion dollar per year....
Here's Why Arbutus Biopharma Corp. Stock Soared Today
Shares of Arbutus Biopharma Corp. (NASDAQ: ABUS) rode some mighty coattails today. This morning, Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) announced highly positive data for a candidate that....
Why Alnylam Pharmaceuticals, Inc. Skyrocketed and Ionis Pharmaceuticals Inc Sank Today
Alnylam Pharmaceuticals (NASDAQ: ALNY) is up more than 40% at 11:53 a.m. EDT after the company released positive phase 3 trial data for the Apollo trial testing its RNAi drug patisiran in patients....
What's Next for Alnylam Pharmaceuticals, Inc.?
The past 15 years haven't been easy for Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) shareholders. The company's new drug candidates are based on science that earned a Nobel Prize in 2006, but....
Why Nabriva Therapeutics Shares Are Falling Today
For the third day in a row Wednesday, shares of Nabriva Therapeutics (NASDAQ: NBRV), a clinical-stage biotech focused on antibiotics, were moving by double-digits. However, today's move is in the....
ALPHA MOS : COMMUNIQUE DE MISE A DISPOSITION DE LA NOTE EN REPONSE
OFFRE PUBLIQUE D'ACHAT SIMPLIFIEE
VISANT LES ACTIONS DE LA SOCIETE
ALPHA MOS
INITIEE CONJOINTEMENT PAR
JOLT CAPITAL
AMBROSIA INVESTMENTS
PRESENTEE PAR
ALANTRA
COMMUNIQUE DE MISE....
